Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Beating Cancer Daily with Saranne Rothberg ~ Stage IV Cancer Survivor

Cancer Humor Buddies with Saranne

25 Oct 2025

Description

In this episode, Saranne discusses the power of developing a comic perspective and the importance of finding a humor buddy to navigate the challenges of cancer treatment. She highlights how laughter and humor can provide respite from the cancer world and shares heartwarming anecdotes about her own humor buddy journey. Tune in to discover the benefits of incorporating laughter into your daily life and how it can positively impact your cancer journey.2025 People’s Choice Podcast Awards Finalist Ranked the Top 5 Best Cancer Podcasts by CancerCare News in 2024 & 2025, and #1 Rated Cancer Survivor Podcast by FeedSpot in 2024 Beating Cancer Daily is listened to in over 130 countries across 7 continents and features over 390 original daily episodes hosted by Stage IV survivor  Saranne Rothberg.   To learn more about Host Saranne Rothberg and The ComedyCures Foundation:https://www.comedycures.org/ To write to Saranne or a guest:https://www.comedycures.org/contact-8 To record a message to Saranne or a guest:https://www.speakpipe.com/BCD_Comments_Suggestions To sign up for the free Health Builder Series live on Zoom with Saranne and Jacqui, go to The ComedyCures Foundation's homepage:https://www.comedycures.org/ Please support the creation of more original episodes of Beating Cancer Daily and other free ComedyCures Foundation programs with a tax-deductible contribution:http://bit.ly/ComedyCuresDonate THANK YOU! Please tell a friend whom we may help, and please support us with a beautiful review. Have a blessed day! Saranne 

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.